Skip to main content
. 2018 Oct 1;145(1):77–86. doi: 10.1007/s00432-018-2757-7

Table 1.

Patient characteristics

Age, median (IQR) 68 (26–90)
Sex, n (%)
 Female 11 (25.6)
 Male 32 (74.4)
Pre-treatment staging, n (%)
 T1, 2 4 (9.3)
 T3, 4 39 (90.7)
 N0 9 (20.9)
 N1, 2 34 (79.1)
 Stages I and II 9 (7.0)
 Stage III 34 (93.0)
Post-treatment staging, n (%)
 ypT1, 2 15 (34.9)
 ypT3, 4 22 (53.5)
 ypN0 29 (67.4)
 ypN1, 2 14 (32.5)
 Stage 0 5 (11.6)
 Stages I and II 25 (58.1)
 Stage III 13 (30.2)